Lisy, K.2014-09-022014-09-022013Clinical Journal of Oncology Nursing, 2013; 17(2):211-2121092-10951538-067Xhttp://hdl.handle.net/2440/84892Objective: To assess whether histamine type 2 receptor antagonists (H2RAs) improve overall survival when used as pre-, peri-, or postoperative therapy in patients with colorectal cancer who had surgical resection with curative intent.en© Oncology Nursing Society.HumansColorectal NeoplasmsHistamine H2 AntagonistsCombined Modality TherapyChemotherapy, AdjuvantHistamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancerJournal article002013804210.1188/13.CJON.211-2120003245638000192-s2.0-8487563623714536Lisy, K. [0000-0003-2604-4290]